首页> 美国卫生研究院文献>Disease Markers >IL-23 Gene Expression in PBMCs of Patients with Coronary Artery Disease
【2h】

IL-23 Gene Expression in PBMCs of Patients with Coronary Artery Disease

机译:冠心病患者PBMCs IL-23基因表达

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objective: Both adaptive and innate immune systems are involved in coronary artery disease (CAD). The aim of this study was to evaluate TH17 cytokines expression profiles in un-stimulated peripheral blood lymphocytes (PBMCs) of patients with coronary artery disease. Methods: Expression profiles of IL-17, IL-23, and TGF-β1 were determined in individuals with and without CAD using Real-time PCR. Results: A significant decrease in IL-23 gene expression in un-stimulated PBMCs of patients with CAD compared to those without CAD was found (p=0.003, OR=0.045, 95% CI: 0.006–0.355). Conclusion: Our data reinforce the potential role of the IL-23 as a critical regulatory molecule that bridges the innate and adaptive arms of the immune system in the complex mechanisms associated with the development of atherosclerosis.
机译:目的:适应性免疫系统和先天性免疫系统均参与冠状动脉疾病(CAD)。这项研究的目的是评估冠心病患者未刺激的外周血淋巴细胞(PBMC)中TH17细胞因子的表达情况。方法:采用实时荧光定量PCR检测有无CAD的个体中IL-17,IL-23和TGF-β1的表达情况。结果:与未使用CAD的患者相比,未使用CAD的患者的PBMC中IL-23基因表达显着降低(p = 0.003,OR = 0.045,95%CI:0.006-0.355)。结论:我们的数据加强了IL-23作为关键调节分子的潜在作用,该分子在与动脉粥样硬化发展相关的复杂机制中架桥了免疫系统的先天和适应臂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号